Stock Analiz

Zenas BioPharma, Inc. (ZBIO) stock forecast and price target

Price $28.01 · data as of November 13, 2026

12-month price target

Average target$47.88
Upside / downside+70.9%
Analysts8
ConsensusStrong buy
Low $32.00Average $47.88High $59.00

Gold marker: average target · white marker: today’s price ($28.01)

Analyst ratings

Strong buy 0Buy 7Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-5.62−16.3%$22M
Next fiscal year
ends December 31, 2027
$-4.82+14.2%$49M
Next quarter
ends December 31, 2026
$-1.31+5.8%$14M
Quarter after
ends March 31, 2027
$-1.40—$0

Consensus of the analysts covering Zenas BioPharma, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Frequently asked questions

What is the Zenas BioPharma stock price target?

The average 12-month target from 8 analysts is $47.88, 70.9% above the current price of $28.01 Targets range from $32.00 to $59.00.

Is Zenas BioPharma a buy according to analysts?

The consensus rating is “Strong buy” (7 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Zenas BioPharma expected to earn?

Analysts expect EPS of $-5.62 for the fiscal year ending December 31, 2026 and $-4.82 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.